Aims 
Joint Action 3 aims to define and implement a sustainable model for the scientific and technical cooperation on Health Technology Assessment (HTA) in Europe. The  voluntary cooperation within and between national and regional HTA Bodies is essential in this joint action.

Aims 
Joint Action 3 aims to define and implement a sustainable model for the scientific and technical cooperation on Health Technology Assessment (HTA) in Europe. The  voluntary cooperation within and between national and regional HTA Bodies is essential in this joint action.

See a full list of all JA2 deliverables below on this page

The general objective of the EUnetHTA Joint Action 2 (JA2) on Health Technology Assessment (HTA) was to strengthen the practical application of tools and approaches to cross-border HTA collaboration. The JA2 aimed at bringing collaboration to a higher level resulting in better understanding for the Commission and Member States of the ways to establish a sustainable structure for HTA in the EU. Specifically, the JA2 was to develop a general strategy, principles and an implementation proposal for a sustainable European HTA collaboration according to the requirements of Article 15 of the Directive for cross-border healthcare. 

The overarching objective of the EUnetHTA Joint Action 1 (JA1) on Health Technology Assessment (HTA) including work on relative effectiveness of pharmaceuticals was to put into practice an effective and sustainable HTA collaboration in Europe that brought added value at the European, national and regional level. The JA brought together HTA agencies and institutional producers of HTA and assessments of pharmaceuticals across Europe.

The EUnetHTA Collaboration was launched in November 2008 in order to continue the work initiated during the EUnetHTA Project 2006-2008. The EUnetHTA Collaboration was funded by the contribution of its participants (i.e. the Founding Partners). In 2009 the EUnetHTA Collaboration was organised into several teams of partners around specific functions where members of each function were assigned according to the individual Founding Partner organisation's preferences of participation.

The overall strategic objective of the network was to connect public national health technology assessment (HTA) agencies, research institutions and health ministries, enabling an affective exchange of information and support to policy decisions by Member States. This implied that the network would help to provide reliable, timely, transparent and transferable information on the short- and long-term effectiveness of health technologies as input to decision-making within the EU.